by Raynovich Rod | Feb 25, 2015 | 2025 Rayno Biopharmaceuticals Portfolio
2/27 Friday After a big February biotechs turned red today with major ETFs off about 1%. In light of recent M&A talk about Pharmacyclics, Inc. (PCYC) at Market Cap of $16.6B we will look at other top Mid-Cap biopharmaceutical stocks for comparison to our motif...
by Raynovich Rod | Feb 12, 2015 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Biotech Stocks Up YTD Despite Choppy Tape NASDAQ 4857.61 approaching March 10, 2000 high of 5048.62 IBB at 320.42 up 5.63% YTD and 351% over 10 Years We have updated our post from 7/1/13 on the Rayno Biopharmaceutical Portfolio with re-balancing. We are approaching...
by Raynovich Rod | Feb 10, 2015 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals, Life Science ETF's and Mutual Funds
Energy Stocks Down-Biotech and Healthcare Stocks Are Leaders NASDAQ Up 1.30% 4787 After a few days in the doldrums biotech stocks rallied across the board escaping the drag of macro news. Healthcare and technology sectors were among the leaders of the day moving...
by Raynovich Rod | Feb 4, 2015 | 2025 Rayno Biopharmaceuticals Portfolio
2/4/15 After the Bell ECB Impasse with Greece Hits Market Near Close…….. NASDAQ 4221 Down 0.19% Oil Plunges 9% to $48.74 on Inventory Rise Biotech Stocks Try To Recover But Get Hit By ECB News At Close ETFs down about 1.6% , XBI Down 1.9%, XLV down 1.24%...
by Raynovich Rod | Jan 27, 2015 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
3:55 p FEDspeak confuses markets with S&P down 1.25% Too much money around too little yield=deflation concerns. Energy takes a big hit again down 4%. Biotechs off 2% and more. ——— Update 1/28 Technology outperforming biotech in mid-day trading...
by Raynovich Rod | Jan 26, 2015 | 2025 Rayno Biopharmaceuticals Portfolio
1/27 Sell-Off Likely Today –Durable Goods Decreased 3.4% In December Green Screen In Biotech Despite Flat Market- Mid-Day Trading 12:45 p 1/26 Most Rayno Life Science stocks were up today in a mixed market where energy is the leading sector. XBI New High at...
by Raynovich Rod | Jan 13, 2015 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
FBT up 2.4% to $108 then drifts back to 107; NASDAQ flat 4661 DOW bounced around in 425 point range. Mixed market among biotech stocks after NASDAQ and S&P sell off; momentum eases. Mid-cap immuno-oncology stocks : down AGIO, BLUE, EPZM, SGEN.; up CLVS, INCY,...
by Raynovich Rod | Jan 1, 2015 | 2024 Rayno Tools and Diagnostics Portfolio, 2025 Rayno Biopharmaceuticals Portfolio
Wishing you all a Happy and Prosperous New Year! Biotech stocks were up 47% in 2014. In 2014 the first quarter was the most volatile. Sign up now to receive all of our market and portfolio updates. In December we posted updates on our Rayno Life Science Portfolios:...
by Raynovich Rod | Dec 22, 2014 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
12/24 Technicals are holding in biotech, buyers coming in, GILD up 2.8% . Update 12/23 Second day of Sell-Off …. Caution Biotech stocks sold off hard for the second day with the “best and biggest” down 3-4%. Analyst reports were circulating about...
by Raynovich Rod | Dec 19, 2014 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals, Macro
Biotech Stocks Rally to New Highs After 4% Correction Buyers Are Bottom Feeding Energy Stocks NASDAQ at 4765 Just as the market appeared to be headed to another test of October lows, challenged by news on slowing global growth and a collapsing energy sector, FED Chair...
